Early Histologic Response and Remission Are Associated With Objective Control of Inflammation After One Year of Treatment With Mirikizumab in Moderately-To-Severely Active Crohn's Disease

AuthID
P-018-4BM
15
Author(s)
Jairath,
·
De Hertogh, G
·
Feagan, B
·
Harpaz, N
·
Hisamatsu, T
·
D'Haens, G
·
Pai, R
·
Yu, G
·
Luo, WT
·
Protic, M
·
Hon, E
·
Moses, R
·
Escobar, R
·
Reinisch, W
Tipo de Documento
Abstract
Year published
2025
Publicado
in JOURNAL OF CROHNS & COLITIS, ISSN: 1873-9946
Volume: 19, Páginas: i188-i189 (2)
Indexing
Publication Identifiers
Wos: WOS:001404198300022
Source Identifiers
ISSN: 1873-9946
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.